TREATMENT OF OSTEOARTHRITIS WITH A HERBOMINERAL FORMULATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY

被引:127
|
作者
KULKARNI, RR
PATKI, PS
JOG, VP
GANDAGE, SG
PATWARDHAN, B
机构
[1] UNIV POONA,INTERDISCIPLINARY SCH AYURVED MED,POONA 411007,MAHARASHTRA,INDIA
[2] UNIV POONA,BRYAMJEE JEEJEEBHOY MED COLL,POONA 411007,MAHARASHTRA,INDIA
[3] UNIV POONA,SASSOON GEN HOSP,POONA 411007,MAHARASHTRA,INDIA
关键词
ARTHRITIS; OSTEOARTHRITIS; CLINICAL TRIAL; HERBOMINERAL; AYURVEDIC;
D O I
10.1016/0378-8741(91)90167-C
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The clinical efficacy of a herbomineral formulation containing roots of Withania somnifera, the stem of Boswellia serrata, rhizomes of Curcuma longa and a zinc complex (Articulin-F), was evaluated in a randomized, double-blind, placebo controlled, cross-over study in patients with osteoarthritis. After a one-month single blind run-in period, 42 patients with osteoarthritis were randomly allocated to receive either a drug treatment or a matching placebo for a period of three months. After a 15-day wash-out period the patients were transferred to the other treatment for a further period of three months. Clinical efficacy was evaluated every fortnight on the basis of severity of pain, morning stiffness, Ritchie articular index, joint score, disability score and grip strength. Other parameters like erythrocyte sedimentation rate and radiological examination were carried out on a monthly basis. Treatment with the herbomineral formulation produced a significant drop in severity of pain (P < 0.001) and disability score (P < 0.05). Radiological assessment, however, did not show any significant changes in both the groups. Side effects observed with this formulation did not necessitate withdrawal of treatment.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 50 条
  • [31] LITHIUM ADDITION TO NEUROLEPTIC TREATMENT IN CHRONIC-SCHIZOPHRENIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY
    TERAO, T
    OGA, T
    NOZAKI, S
    OHTA, A
    OHTSUBO, Y
    YAMAMOTO, S
    ZAMAMI, M
    OKADA, M
    ACTA PSYCHIATRICA SCANDINAVICA, 1995, 92 (03) : 220 - 224
  • [32] Intravenous immunoglobulin treatment in multifocal motor neuropathy with conduction block: A double-blind, placebo-controlled, cross-over study
    Federico, P
    Zochodne, DW
    Feasby, TE
    NEUROLOGY, 1999, 52 (06) : A127 - A127
  • [33] BODY-COMPOSITION IN ACTIVE ACROMEGALY DURING TREATMENT WITH OCTREOTIDE - A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSS-OVER STUDY
    HANSEN, TB
    GRAM, J
    BJERRE, P
    HAGEN, C
    BOLLERSLEV, J
    CLINICAL ENDOCRINOLOGY, 1994, 41 (03) : 323 - 329
  • [34] Gabapentin reduces chronic benign nociceptive pain: a double-blind, placebo-controlled cross-over study
    McCleane, GJ
    PAIN CLINIC, 2000, 12 (02): : 81 - 85
  • [35] EFFECTS OF CISAPRIDE ON CONSTIPATION IN PARAPLEGIC PATIENTS - A PLACEBO-CONTROLLED RANDOMIZED DOUBLE-BLIND CROSS-OVER STUDY
    DEBOTH, PSM
    DEGROOT, GH
    SLOOTMAN, HR
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1992, 4 (12) : 1013 - 1017
  • [36] Gabapentin in postamputation phantom limb pain: A randomized, double-blind, placebo-controlled, cross-over study
    Bone, M
    Critchley, P
    Buggy, DJ
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2002, 27 (05) : 481 - 486
  • [37] Modified ketogenic diet in patients with McArdle disease: A double-blind, placebo-controlled, cross-over study
    Lokken, N.
    Nielsen, M.
    Stemmerik, M.
    Ellerton, C.
    Macrae, M.
    Revsbech, K.
    Krett, B.
    Beha, G.
    Quinlivan, R.
    Vissing, J.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S73 - S73
  • [38] Effects of meloxicam and rofecoxib on psychomotor performance: A randomized, double-blind, placebo-controlled cross-over study
    Al-Nimer, Marwan S. M.
    INDIAN JOURNAL OF PHARMACOLOGY, 2007, 39 (06) : 291 - 293
  • [39] Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial
    Kanhai, Kawita M. S.
    Bijvank, Jenny A. Nij
    Wagenaar, Yorick L.
    Klaassen, Erica S.
    Lim, KyoungSoo
    Bergheanu, Sandrin C.
    Petzold, Axel
    Verma, Ajay
    Hesterman, Jacob
    Wattjes, Mike P.
    Uitdehaag, Bernard M. J.
    van Rijn, Laurentius J.
    Groeneveld, Geert Jan
    CNS NEUROSCIENCE & THERAPEUTICS, 2019, 25 (06) : 697 - 703
  • [40] Lorazepam for chronic catatonia: a randomized, double blind, placebo-controlled cross-over study
    Ungvari, GS
    Chiu, HFK
    Chow, LY
    Lau, BST
    Tang, WK
    PSYCHOPHARMACOLOGY, 1999, 142 (04) : 393 - 398